Alx Oncology Holdings Inc (NASDAQ:ALXO) currently has a daily average trading volume of 797.86K but it saw 549087 shares traded in last market. With a market cap of 24.55M USD, the company’s current market price of $0.46 came falling about -4.49 while comparing to the previous closing price of $0.48. In past 52 weeks, the stock remained buoying in the range of price level as high as $16.29 and as low as $0.41.
Taking a look at 20-day trading activity of Alx Oncology Holdings Inc (ALXO) gives us an average price of $0.5208, while its current price level is -97.18% below from 52-week high level whereas it is 12.05% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $0.6397 while that of 200 days or SMA-200 reads an average of $1.5000. A closer look into the stock’s movement over the week reveals that its volatility is standing at 13.86% during that period while stretching the period over a month that decreases to 10.62%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 38.72 which implies that the stock is in neutral territory.
The company’s shares got several price updates from the analyst firms in past one month and most recent of them is from the Jefferies which upgraded the stock as “Buy” in its note to investors issued on March 06, 2025, recommending a price target of between $2 and $3 for it. Jefferies downgraded its recommendation for the stock as a “Hold” from “Buy” on December 19, 2024 while assigning a price target range of $12-$2. Stifel issued its recommendations for the stock as it downgraded the price target for the stock in the range of between $10 and $14.
Over the week, ALXO’s stock price is moving -5.10% down while it is -8.36% when we observe its performance for the past one month. Year-to-date it is -72.49% down and over the past year, the stock is showing a downside performance of -97.17%.
The company is expected to be releasing its next quarterly report in June, for which analysts forecasted an EPS of -0.28 while estimate for next year EPS is -1.02.
Currently, Alx Oncology Holdings Inc’s total number of outstanding shares is 53.38M with 2.11% of that held by the insiders while 85.17% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -128.50% and return on equity (ROE) at -102.99%. Stock’s beta reads 1.15. Stock has a price to book (P/B) ratio of 0.28. Its return on asset (ROA) is -77.96% on average.
